{"filing":{"accession_number":"0001213900-26-066896","cik":"0001704287","ticker":"BJDX","company_name":"Bluejay Diagnostics, Inc.","form":"8-K","filing_date":"2026-06-09","report_date":null,"primary_document":"ea0294209-8k_bluejay.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026066896/ea0294209-8k_bluejay.htm"},"events":[{"id":5969,"run_id":5237,"accession_number":"0001213900-26-066896","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Bluejay Diagnostics held its Annual Meeting on June 9, 2026, and reported shareholder voting results on four proposals: director elections, authorization of a reverse stock split, approval of Amendment No. 1 to the 2021 Stock Plan (increasing share reserve by 600,000 shares), and ratification of Wolf \u0026 Company as independent auditor.","company_name":"Bluejay Diagnostics, Inc.","ticker":"BJDX","filing_date":"2026-06-09","form":"8-K","submitted_at":null,"items":[{"id":5652,"accession_number":"0001213900-26-066896","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure centers on stockholder approval of Amendment No. 1 to the 2021 Stock Plan, which increases the share reserve by 600,000 shares. This is a compensatory arrangement amendment affecting equity grants available to officers and directors. While the Item 5.02 header is broad, the substantive event is the plan amendment itself, which is material to investors assessing dilution and executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T21:27:08.070081+00:00","company_name":"","ticker":null,"filing_date":""},{"id":5653,"accession_number":"0001213900-26-066896","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Bluejay Diagnostics' Annual Meeting held on June 9, 2026. The filing reports final voting tallies for four proposals: director elections, a reverse stock split authorization, a stock plan amendment increasing available shares by 600,000, and ratification of Wolf \u0026 Company as independent auditor. The reverse stock split authorization and stock plan amendment are material corporate actions requiring shareholder approval.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T21:27:08.070081+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5652,"accession_number":"0001213900-26-066896","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure centers on stockholder approval of Amendment No. 1 to the 2021 Stock Plan, which increases the share reserve by 600,000 shares. This is a compensatory arrangement amendment affecting equity grants available to officers and directors. While the Item 5.02 header is broad, the substantive event is the plan amendment itself, which is material to investors assessing dilution and executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T21:27:08.070081+00:00","company_name":"Bluejay Diagnostics, Inc.","ticker":"BJDX","filing_date":"2026-06-09"},{"id":5653,"accession_number":"0001213900-26-066896","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Bluejay Diagnostics' Annual Meeting held on June 9, 2026. The filing reports final voting tallies for four proposals: director elections, a reverse stock split authorization, a stock plan amendment increasing available shares by 600,000, and ratification of Wolf \u0026 Company as independent auditor. The reverse stock split authorization and stock plan amendment are material corporate actions requiring shareholder approval.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T21:27:08.070081+00:00","company_name":"Bluejay Diagnostics, Inc.","ticker":"BJDX","filing_date":"2026-06-09"}]}